As part of new projections into the 2030s, BP cut its demand forecasts for crude oil by 2035 and raised expectations for…
McAlinden Research PartnersJanuary 31, 2023
Expectations for AI in healthcare, particularly biopharma and diagnostics, have been high for several years now. New partnerships and acquisitions may…
McAlinden Research PartnersJanuary 17, 2023
Oil Prices are on a hot streak despite a recent spate of bearish supply data. Though crude stockpiles just recorded…
McAlinden Research PartnersJanuary 12, 2023
Southeast Asia's vibrant tourist economy has suffered several down years, resulting from the COVID-19 pandemic. 2023 may be the year…
McAlinden Research PartnersJanuary 9, 2023
The biopharma industry is kicking off the year with price hikes and some early signs of a sustained uptick in…
McAlinden Research PartnersJanuary 5, 2023
Gold has continued its ongoing rally into the new year on hopes that the Fed's rapid pace of tightening is…
McAlinden Research PartnersJanuary 4, 2023
Ukrainian President Zelensky's first international trip since Russia's invasion of his country was to the US, culminating in an address…
McAlinden Research PartnersDecember 22, 2022
Oil prices have rebounded throughout the week, despite a significant build in commercial stockpiles. Part of that can likely be chalked up…
McAlinden Research PartnersDecember 15, 2022
Saudi Arabia remains on track to be the fastest-growing major economy in the world this year while posting a budget…
McAlinden Research PartnersDecember 13, 2022
